Long-Term Evaluation of the Impact of the H1-Receptor Antagonist Cetirizine on the Behavioral, Cognitive, and Psychomotor Development of Very Young Children with Atopic Dermatitis

@article{Stevenson2002LongTermEO,
  title={Long-Term Evaluation of the Impact of the H1-Receptor Antagonist Cetirizine on the Behavioral, Cognitive, and Psychomotor Development of Very Young Children with Atopic Dermatitis},
  author={J. J. Stevenson and Deborah Cornah and Philippe P Evrard and Valere Vanderheyden and Catherine Billard and Martin Bax and Anne Van Hout},
  journal={Pediatric Research},
  year={2002},
  volume={52},
  pages={251-257}
}
The impact of the prolonged use of cetirizine at high dose (0.25 mg/kg twice a day over 18 mo) on behavior and cognitive ability was examined in a double-blind, randomized, placebo-controlled trial (ETAC—Early Treatment of the Atopic Child) designed to establish whether it was possible to prevent young children (1–2 y old at study entry) with atopic… CONTINUE READING